NCPAP在治疗新生儿急性呼吸衰竭中的应用价值被引量：2

Application of NCPAP in the Treatment of Acute Respiratory Failure in Neonates

导出

摘要目的:探讨鼻塞持续正压通气(NCPAP)治疗新生儿急性呼吸衰竭的临床应用价值。方法:选取我院2008年2月至2014年5月接收确诊的新生儿急性呼吸衰竭98例,根据治疗方法不同均分为对照组和治疗组,每组49例,对照组采用持续头罩吸氧治疗,治疗组采用鼻塞持续正压无创通气治疗,对比分析两组患儿的治疗效果。结果:治疗24 h后,治疗组患儿的呼吸、心率、Pa O2和Pa CO2临床指标改善程度要高于对照组(P<0.05),且治疗组的治愈率高于对照组(89.4%>67.4%,X2=3.671,P<0.05),同时并发症的发生率低于对照组(P<0.05)。结论:NCPAP能够有效地治疗新生儿急性呼吸衰竭,同时减少并发症的发生,值得临床进一步推广与应用。 Objective： To explore the clinical application value of NCPAP （Nasal Continuous Positive Airway Pressure） in the treatment of neonatal acute respiratory failure. Methods： 98 cases in our hospital from February 2008 to May 2014 which were selected, then were equally into the treatment group and the control group according to the different treatment methods, with 49 cases in each group. The control group was treated with continuous mask oxygen, the treatment group was treated with nasal continuous positive pressure ventilation （NCPAP）. The curative effect of the two groups were compared and analyzed. Results： At 24 h after treatment, the clinical indexes of respiratory, heart rate, PaO2 and PaCO2 in the treatment group were improved more obviously than that of the control group （P〈0.05）, and the cure rate was in treatment group than that of the control group （89.4 %〉67.4 %, x^2=3.671, P〈0.05）, and the incidence of complications was lower than that of the control group （P〈0.05）. Conclusions： NCPAP can effectively treat neonatal acute respiratory failure, and reduce the occurrence of complications, it is worthy of further clinical promotion and application.

作者梅玲华刘增芳贺兆平侯伟鱼建飞

机构地区陕西省榆林市第二医院儿科西安交通大学第二附属医院儿科

出处《现代生物医学进展》 CAS 2015年第34期6725-6727,共3页 Progress in Modern Biomedicine

关键词 NCPAP 新生儿急性呼吸衰竭 NCPAP Neonatus Acute respiratory failure

分类号 R720.59 [医药卫生—儿科]

引文网络
相关文献

参考文献20

1Carrion A, Schwartz J, Mukkada S, et al. Casting a Shadow. A 13-Year-Old Girl with Acute Chest Syndrome and Respiratory Failure [J]. Ann Am Thorac Soc, 2015, 12(7): 1097-1099.
2Lakshmiurusimha S. The Pulmonary Circulation in Neonatal Respiratory Failure[J]. Clinics in Perinatology, 2012, 3(39): 655-683.
3Beurskens C J, Wtisten-van Asperen RM, Preckel B, et al. The potentialof heliox as a therapy for acute respiratory distress syndrome in adults and children: a descriptive review [J]. Respiration, 2015, 89 (2): 166-174.
4Fettah N, Dilli D, Beken S, et al. Surfactant for acute respiratory distress syndrome caused by near drowning in a newborn [J]. Pediatr Emerg Care, 2014, 30(3): 180-181.
5Dechert RE, Park PK, Bartlett RH. Evaluation of the oxygenation index in adult respiratory failure[J]. J Trauma Acute Care Surg, 2014, 76(2): 469-473.
6Schnell D, Timsit JF, Darmon M, et al. Noninvasivc mechanical ventilation in acute respiratory failure: trends in use and outcomes[J]. Intensive Care Medicine, 2014, 40(4): 582-591.
7Chidini G, Calderini E, Cesana BM, et al. Noninvasive Continuous Positive Airway Pressure in Acute Respiratory Failure: Helmet Versus Facial Mask [J]. Pediatrics, 2010, 126(2): 330-336.
8Bembich S, Travan L, Cont G, et al. Cerebral oxygenation with different nasal continuous positive airway pressure levels in preterm infants [J]. Arch Dis Child Fetal Neonatal Ed, 2015, 100(2): 165-168.
9Djeddi D, Cantin D, Samson N, et al. Nasal Continuous Positive Airway Pressure Inhibits Gastroesophageal Reflux in Newborn Lambs [J]. PLoS One, 2014, 9(9): 1-5.
10Hemani R, Narayanan M, Jeffries-Stokes C, et al. Successful Nasal Continuous Positive Airway Pressure for Newborn Respiratory Distress in a Regional Centre [J]. Journal of Paediatrics and Child Health, 2014, 50(1): 86.